Spinal cord atrophy as a primary outcome measure in phase II trials of progressive multiple sclerosis

Abstract

Objectives:

To measure the development of spinal cord (SC) atrophy over 1 year in patients with progressive multiple sclerosis (PMS) and determine the sample sizes required to demonstrate a reduction in spinal cord cross-sectional area (SC-CSA) as an outcome measure in clinical trials.

Methods:

In total, 44 PMS patients (26 primary progressive multiple sclerosis (PPMS), 18 secondary progressive multiple sclerosis (SPMS)) and 29 healthy controls (HCs) were studied at baseline and 12 months. SC-CSA was measured using the three-dimensional (3D) fast field echo sequences acquired at 3T and the active surface model. Multiple linear regressions were used to investigate changes in imaging measurements.

Results:

PPMS patients had shorter disease duration, lower Expanded Disability Status Scale (EDSS) and larger SC-CSA than SPMS patients. All patients together showed a significantly greater decrease in percentage SC-CSA change than HCs, which was driven by the PPMS. All patients deteriorated over 1 year, but no association was found between percentage SC-CSA change and clinical changes. The sample size per arm required to detect a 50% treatment effect over 1 year, at 80% power, was 57 for PPMS and 546 for SPMS.

Conclusion:

SC-CSA may become an outcome measure in trials of PPMS patients, when they are at an early stage of the disease, have moderate disability and modest SC atrophy.

Keywords

Multiple sclerosis spinal cord progressive magnetic resonance imaging atrophy

Get full access to this article

View all access options for this article.

References

Bot

Blezer

Kamphorst

et al . The spinal cord in multiple sclerosis: Relationship of high-spatial-resolution quantitative MR imaging findings to histopathologic results. Radiology 2004; 233: 531–540.

Kearney

Miller

Ciccarelli

. Spinal cord MRI in multiple sclerosis – Diagnostic, prognostic and clinical value. Nat Rev Neurol 2015; 11(6): 327–338.

Kearney

Rocca

Valsasina

et al . Magnetic resonance imaging correlates of physical disability in relapse onset multiple sclerosis of long disease duration. Mult Scler 2014; 20: 72–80.

Lukas

Knol

Sombekke

et al . Cervical spinal cord volume loss is related to clinical disability progression in multiple sclerosis. J Neurol Neurosurg Psychiatry 2015; 86: 410–418.

De Stefano

Giorgio

Battaglini

et al . Assessing brain atrophy rates in a large population of untreated multiple sclerosis subtypes. Neurology 2010; 74: 1868–1876.

Kapoor

Furby

Hayton

et al . Lamotrigine for neuroprotection in secondary progressive multiple sclerosis: A randomised, double-blind, placebo-controlled, parallel-group trial. Lancet Neurol 2010; 9: 681–688.

Yaldizli

MacManus

Stutters

et al . Brain and cervical spinal cord atrophy in primary progressive multiple sclerosis: Results from a placebo-controlled phase III trial (INFORMS). In: Proceedings of the ECTRIMS, 2015, http://discovery.ucl.ac.uk/1510207/

Kearney

Altmann

Samson

et al . Cervical cord lesion load is associated with disability independently from atrophy in MS. Neurology 2015; 84(4): 367–373.

Abdel-Aziz

Schneider

Solanky

et al . Evidence for early neurodegeneration in the cervical cord of patients with primary progressive multiple sclerosis. Brain 2015; 138: 1568–1582.

10.

Polman

Reingold

Edan

et al . Diagnostic criteria for multiple sclerosis: 2005 revisions to the ‘McDonald Criteria’. Ann Neurol 2005; 58(6): 840–846.

11.

Kurtzke

. Rating neurologic impairment in multiple sclerosis: An expanded disability status scale (EDSS). Neurology 1983; 33: 1444–1452.

12.

Cutter

Baier

Rudick

et al . Development of a multiple sclerosis functional composite as a clinical trial outcome measure. Brain 1999; 122(Pt 5): 871–882.

13.

Fischer

Rudick

Cutter

et al . The Multiple Sclerosis Functional Composite Measure (MSFC): An integrated approach to MS clinical outcome assessment. National MS Society Clinical Outcomes Assessment Task Force. Mult Scler 1999; 5: 244–250.

14.

Svens

Lee

. Intra- and inter-instrument reliability of Grip-Strength measurements: GripTrack™ and Jamar^® hand dynamometers. Hand Ther 2005; 10: 47–55.

15.

Maynard

Jr Bracken

Creasey

et al . International standards for neurological and functional classification of spinal cord injury. American Spinal Injury Association. Spinal Cord 1997; 35: 266–274.

16.

Horsfield

Sala

Neema

et al . Rapid semi-automatic segmentation of the spinal cord from magnetic resonance images: Application in multiple sclerosis. Neuroimage 2010; 50: 446–455.

17.

Chard

Jackson

Miller

et al . Reducing the impact of white matter lesions on automated measures of brain gray and white matter volumes. J Magn Reson Imaging 2010; 32: 223–228.

18.

Cardoso

Leung

Modat

et al . STEPS: Similarity and Truth Estimation for Propagated Segmentations and its application to hippocampal segmentation and brain parcelation. Med Image Anal 2013; 17(6): 671–684.

19.

Smith

De Stefano

Jenkinson

et al . Normalized accurate measurement of longitudinal brain change. J Comput Assist Tomogr 2001; 25(3): 466–475.

20.

Rocca

Valsasina

Damjanovic

et al . Voxel-wise mapping of cervical cord damage in multiple sclerosis patients with different clinical phenotypes. J Neurol Neurosurg Psychiatry 2013; 84(1): 35–41.

21.

Evangelou

DeLuca

Owens

et al . Pathological study of spinal cord atrophy in multiple sclerosis suggests limited role of local lesions. Brain 2005; 128(Pt 1): 29–34.

22.

Ciccarelli

Altmann

McLean

et al . Spinal cord repair in MS: Does mitochondrial metabolism play a role? Neurology 2010; 74(9): 721–727.

23.

Brownlee

Altmann

Alves

Mota

et al . Association of asymptomatic spinal cord lesions and atrophy with disability 5 years after a clinically isolated syndrome. Mult Scler 2017; 23: 665–674.

24.

Rocca

Horsfield

Sala

et al . A multicenter assessment of cervical cord atrophy among MS clinical phenotypes. Neurology 2011; 76: 2096–2102.

25.

Yiannakas

Kearney

Samson

et al . Feasibility of grey matter and white matter segmentation of the upper cervical cord in vivo: A pilot study with application to magnetisation transfer measurements. Neuroimage 2012; 63(3): 1054–1059.

26.

Yiannakas

Mustafa

De Leener

et al . Fully automated segmentation of the cervical cord from T1-weighted MRI using PropSeg: Application to multiple sclerosis. Neuroimage Clin 2015; 10: 71–77.

27.

Kearney

Yiannakas

Abdel-Aziz

et al . Improved MRI quantification of spinal cord atrophy in multiple sclerosis. J Magn Reson Imaging 2014; 39(3): 617–623.

28.

Prados

Cardoso

Yiannakas

et al . Fully automated grey and white matter spinal cord segmentation. Sci Rep 2016; 6: 36151.